SLBT$1.119.02%-0.11
After Hours: 1.16+0.05 +4.50%
Sl Science Holding Ltd (SLBT)
Date: 2026-11-04 16:00O: 1.20H: 1.22L: 1.10C: 1.11Vol: 39.58k
Sl Science Holding Ltd stock is traded at $1.11, with a volume of 39,584. It is down -9.02% in the last 24 hours and down -29.30% over the past month. SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.
Previous Close:
$1.22
Open:
$1.20
24h Volume:
39,584
Relative Volume:
1.38
Market Cap:
$622.44M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-8.26%
1M Performance:
-29.30%
6M Performance:
0.00%
1Y Performance:
0.00%
1-Day Range:
$1.10$1.22
1-Week Range:
$1.10$1.43
52-Week Range:
$1.02$14.50
Sl Science Holding Ltd Stock (SLBT) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS
Sl Science Holding Ltd Stock (SLBT) Financials Data
There is no financial data for Sl Science Holding Ltd (SLBT). Check out other stocks for more information.
Sl Science Holding Ltd Stock (SLBT) Insider Trading
- Wang Ching-DongSep 29 '26Chief Executive Officer
- Transaction
- Buy
- Cost
- $0.5
- #Shares
- 4,545,306
- Value ($)
- 2,272,653
- #Shares Total
- 333,832,129
